Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Harvest T cells before chemo for ALL

Barrett DM et al. AACR 2018, Abstract 1631

Key clinical point: Prior exposure to chemotherapy may degrade the potential of T cells to become CAR T cells, suggesting a benefit of harvesting T cells before any chemotherapy.

Major finding: Only T cells taken from ALL and Wilm’s tumor patients before chemotherapy achieved a fivefold expansion in response to CD3/CD28 exposure for 7 days.

Study details: An examination of T cells from 157 pediatric patients with a variety of cancers at diagnosis and after each cycle of chemotherapy.

Disclosures: The study was supported by the American Association of Cancer Research, the Doris Duke Charitable Foundation Clinical Science Development Award, the Jeffrey Pride Foundation Research Award, and the St. Baldrick’s Foundation Scholar Award. Dr. Barrett and his coauthors had no financial disclosures.

Source: Barrett DM et al. AACR 2018, Abstract 1631.

Read the full article.

Citation:

Barrett DM et al. AACR 2018, Abstract 1631